sitefansalaran International News

Global CINV Existing and Pipeline Drugs Market, valued at USD 1.69 Billion in 2024, is projected to grow at a CAGR of 4.9% from 2025 to 2032, reaching approximately USD 2.49 Billion. Global CINV Existing and Pipeline Drugs Market Overview: Innovative Antiemetic Therapies, Rising Cancer Prevalence, and Next-Generation Chemotherapy Support Driving Growth Global CINV Existing and Pipeline Drugs Market is rapidly evolving, driven by rising cancer prevalence and breakthrough antiemetic therapies such as Aloxi, Akynzeo, Emend, and Rolapitant. Increasing adoption of CINV pipeline drugs across hospitals, specialty clinics, and pharmacy channels, coupled with clinical advancements by key players like GSK, Helsinn, and Heron Therapeutics, is reshaping chemotherapy-induced nausea and vomiting management, presenting lucrative opportunities, heightened competition, and a forward-looking growth trajectory in supportive oncology care.

Medical diagnostics firm Hologic has agreed to be acquired by Blackstone and TPG in a deal valued at up to $18.3 billion, it said on Tuesday, marking one of the largest healthcare take-private transactions this year. The company, which specializes in women's health diagnostics, including breast and cervical cancer screening, has grappled with waning demand since the COVID-19 pandemic, as well as rising competition. Under the agreement, Blackstone and TPG will pay $76 apiece in cash to buy all outstanding Hologic shares, implying a premium of nearly 6% to the stock's last close. Hologic shares were up nearly 4% in early trading. They have gained 13.5% since Reuters reported last month that Blackstone and TPG revived their interest after intermittent talks between the parties over the past year. Shareholders are also eligible for a non-tradable right to receive up to $3 per share, contingent on certain global revenue goals for its breast health business in fiscal years 2026 and 2027, bringing the total potential payout to $79 per share. In May, the Financial Times reported that Hologic had rejected a $70 to $72 per share offer from the private equity firms. The offer seems "fair for all parties," BTIG analyst Ryan Zimmerman said on Tuesday,...

The World Health Organization (WHO) and the European Union (EU) announced today a new agreement to support the digital transformation of health systems and wider adoption of WHO’s Global Digital Health Certification Network (GDHCN) in sub-Saharan Africa. This EU–WHO partnership will improve pandemic preparedness and accelerate progress towards better health and well-being for all. The agreement was announced at the World Health Summit 2025 by Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data; Dr Mohamed Yakub Janabi, WHO Regional Director for Africa; and Mr Martin Seychell, Deputy Director-General of the European Commission Directorate-General for International Partnerships. The GDHCN is a global system that enables countries to securely and reliably verify nationally approved digital health credentials across borders. The system builds on the European Union Digital COVID Certificate (EU DCC), which facilitated verification of vaccination, testing and recovery certification for international travelers connecting 76 countries and territories. However, only four countries from the WHO African Region—Benin, Cabo Verde, Seychelles and Togo—were able to join the EU DCC network. Since its transfer to the WHO in 2023, the GDHCN has shown strong potential to support the digitization of the International Certificate of Vaccination or Prophylaxis (ICVP), commonly known as the...

The Ministry of Human Resources and Social Development, in collaboration with the Ministry of Health of Saudi Arabia, has announced the implementation of the second phase of the decision to increase Saudization rates for four health professions within the private sector. The decision which comes into effect on Oct. 17, 2025, in line with the approved professional definitions and classifications. Under the new regulation, clinical nutrition and physical therapy professions are required to achieve an 80 percent Saudization rate, medical laboratories 70 percent, and radiology 65 percent. The minimum salary has been set at SR.7,000 for specialists and SR.5,000 for technicians. The decision applies to all private healthcare facilities across the Kingdom. The Ministry of Human Resources and Social Development has published procedural guidelines on its official website, outlining implementation details and Saudization ratios. It also urged establishments to comply with the decision to avoid regulatory penalties. The initiative builds on previous efforts to nationalize health professions, with the Ministry of Health supervising implementation to ensure alignment with labor market requirements. Private sector institutions will receive support and incentives through the human resources system, including recruitment assistance, training, qualification, employment sustainability, and priority access to Saudization and Human Resources Development Fund (HADAF) programmes. The decision aims...

World Osteoporosis Day, marked on October 20th each year, is a prime time to put the spotlight on osteoporosis. Below, read about this year’s campaign theme, and how you can get involved and support the campaign in a number of ways. ABOUT THE 2025 WORLD OSTEOPOROSIS DAY CAMPAIGN "It’s Unacceptable!" puts the spotlight on the persistent and preventable crisis in osteoporosis care. Despite affecting over 500 million people worldwide, osteoporosis remains severely underdiagnosed and undertreated—especially among those who have already sustained fragility fractures. Shockingly, up to 80% of patients with osteoporotic fractures receive no follow-up diagnosis or treatment. The consequences are devastating: chronic pain, disability, loss of independence, increased risk of future fractures, and premature death. Families, healthcare systems, and economies also shoulder the heavy burden of this neglect. The campaign demands an end to the neglect in prevention and care, and urgent policy action. At a time when effective diagnostic tools, treatments, and programmes like Fracture Liaison Services exist, the continued inaction is indefensible. With aging populations and fracture rates rising, osteoporosis must be prioritized across all stages of life—from prevention in youth to post-fracture care. "It’s Unacceptable!" calls on the public, healthcare providers, and health authorities to close the treatment gap,...

German biotech firm Tubulis said on Wednesday it had raised 308 million euros ($358 million) in its biggest financing round to date, contributing to a total of 495 million euros earmarked for advancing its research into targeted cancer therapies. Tubulis is developing targeted cancer treatment, specifically antibody-drug conjugates often referred to as “guided missiles,” which deliver chemotherapy directly to cancer cells while minimizing harm to healthy tissue. The market for these treatments is projected to reach $31 billion by 2030 based on currently approved drugs and could expand further, analysts at TD Cowen estimated. The financing signals that investors continue to think of such targeted therapies as a lucrative market, despite a prolonged period of tight financing in the biotech industry. “It’s a very competitive space, and the reason why it’s competitive is because this format is really providing benefit for patients,” said Tubulis CEO Dominik Schumacher. Schumacher said the funds will be used to test the company’s lead product – known as TUB-040 – in earlier lines of therapy and additional cancers. The drug binds to NaPi2b, a protein found in certain cancer cells, and is being tested as a treatment for platinum-resistant ovarian cancer and a common form lung cancer. Data from its ovarian...

A coalition of 15 U.S. state governors representing more than a third of the country's population has launched a new bipartisan alliance on Wednesday, aimed at improving public health coordination and emergency preparedness. The Governors Public Health Alliance will serve as a hub for governors and public health officials to share best practices, exchange data and collaborate on emergency response, vaccine policy and other technical issues, according to a joint statement from the coalition. The alliance of mostly Democratic states and territories comprises Colorado, California, Connecticut, Delaware, Hawaii, Illinois, Maryland, Massachusetts, New Jersey, New York, North Carolina, Oregon, Rhode Island, Washington and Guam. "While Donald Trump and RFK Jr. turn their backs on public health, Governors are stepping up to make sure our residents have the health care they need and deserve," Massachusetts Governor Maura Healey said. Severe budget reductions due to current and proposed federal cuts and funding pullbacks under the Trump administration have put public health at risk, the governors said. "Democrat-led states that imposed unscientific school closures, toddler mask mandates, and vaccine passports during the COVID era are the ones who destroyed public trust in public health," U.S. Department of Health and Human Services spokesperson Andrew Nixon said in a statement...

Britain's competition regulator proposed sweeping reforms to the country's $8 billion veterinary services market on Wednesday, saying pet owners often lack clear information on prices and overpay for medicines. However, the Competition and Markets Authority's provisional findings from a review of the sector were broadly as expected and did not include any negative surprises, analysts said, alleviating uncertainty that has pressured shares of vet services groups. Shares of CVS Group (CVSG.L), opens new tab, which operates about 470 veterinary practices across the UK and Australia and was one of six large veterinary groups named in the CMA's investigation, soared as much as 18% in early trade in London. Pets At Home (PETSP.L), opens new tab, which was also named as one of the large vet groups, rose as much as 4.5%. The CMA said pet owners pay about 17% more on average at large veterinary chains than at independent clinics, with average prices across the sector surging 63% between 2016 and 2023, and far outpacing inflation. The regulator's proposed measures include requiring vet businesses to publish comprehensive price lists, creating a price comparison website and capping prescription fees at 16 pounds. "Pet owners are often left in the dark, not knowing whether their practice...

CBC Group, Asia's largest healthcare-focused asset manager, has raised $500 million for its second R-Bridge Healthcare Fund, making it the region's biggest healthcare private credit fund, the company said on Wednesday. The fundraising is occurring amid a global expansion of private credit providers, with the value of loans and related investments projected to reach $3 trillion by 2028, doubling from that in 2023, according to forecasts from Moody's. Healthcare has emerged as a key driver for the private credit sector, accounting for about 20% of direct lending deals in 2024, according to Prospect Capital, citing PitchBook data, as investors seek stable returns in non-cyclical sectors such as pharmaceuticals and medical technology. Singapore-based CBC Group, which manages about $11 billion in assets, launched its private credit and drug royalty strategy in 2020. The new fund is 66.7% larger than its predecessor, which raised $300 million in 2020 as a single-investor strategy focused on China. "This $500 million raise is significant because we went from one investor to a diversified group of investors across sovereign wealth funds, corporate pensions, financial institutions and family offices from the U.S., Europe, Asia and the Middle East," Michael Keyoung, Senior Managing Director and Head of Private Credit and Royalty...

Pfizer Chief Executive Albert Bourla said on Tuesday that the U.S. pharmaceutical industry needs to collaborate with China’s, where speedy processes have vaulted it to 30% of global drug development over the past decade. "In biopharma, China's dramatic speed, cost and scale have triggered a shift in the global competitive landscape," Bourla said, speaking at the National Committee on U.S.-China Relations Gala in New York. He said the country currently has around 1,200 novel drug candidates, compared with 10 years ago when there was about 60. The remarks come as U.S. President Donald Trump has targeted top economic rival China with a cascade of tariff orders on billions of dollars of imported goods that he says is aimed at narrowing a wide trade deficit, bringing back lost manufacturing and crippling the fentanyl trade. The U.S. House of Representatives also passed a bill last year that aimed to restrict U.S. business with Chinese pharmaceutical companies. The measure ultimately did not pass the Senate, but a new version of the bill was reintroduced earlier this year. Nonetheless, U.S. and European drug companies have also looked to China to replenish their drug pipelines, despite the trade war between Beijing and Washington. Earlier this year, Pfizer struck a deal...